SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Bacterial Robotics, LLC (Last) (First) (Middle) PO BOX 30085 (Street) CINCINNATI OH 45230 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol TAURIGA SCIENCES, INC. [ TAUG ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 01/25/2014
	4. If Amendment, Date of Original Filed (Month/Day/Year) 05/02/2014	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/25/2014		J(1)		3,500,000	A	$0	3,500,000	D
Common Stock	02/27/2014		P		1,000(2)	A	$0.0175	3,501,000	D
Common Stock	03/04/2014		P		10,000	A	$0.0235	10,000(3)	D
Common Stock	03/17/2014		P		10,000	A	$0.0995	20,000(3)	D
Common Stock	03/27/2014		P		20,000	A	$0.07	40,000(3)	D
Common Stock	03/28/2014		P		10,000	A	$0.064	50,000(3)	D
Common Stock	03/28/2014		P		10,000	A	$0.06	60,000(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock Warrants (Right to Buy)	$0.02	01/28/2014		J(4)		71,082,323(5)		01/28/2014	01/28/2021	Common Stock	71,082,323	$0	71,082,323	I	By group(5)
Common Stock Warrants (Right to Buy)	$0.02	01/28/2014		J(4)		28,917,647(6)		01/28/2014	01/28/2021	Common Stock	28,917,647	$0	28,917,647	D

1. Name and Address of Reporting Person* Bacterial Robotics, LLC (Last) (First) (Middle) PO BOX 30085 (Street) CINCINNATI OH 45230 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Barkeloo Jason Eric (Last) (First) (Middle) PO BOX 30085 (Street) CINCINNATI OH 45230 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

1. The shares of common stock were issued on January 25, 2014 to Jason E. Barkeloo ("Mr. Barkeloo"), a reporting person hereunder, in consideration of Mr. Barkeloo's services to Tauriga Sciences, Inc. (the "Company") pursuant to an advisory agreement between the Company and Mr. Barkeloo, and are owned directly and solely by Mr. Barkeloo.

2. The shares of common stock are owned directly and solely by Mr. Barkeloo.

3. The shares of common stock are owned directly by Bacterial Robotics, LLC ("Bacterial Robotics"), a reporting person hereunder. As managing member and Chief Executive Officer of Bacterial Robotics and by virtue of the Voting Agreement (defined below), as disclosed in the reporting persons' Schedule 13D filed with the Securities and Exchange Commission on May 2, 2014, Mr. Barkeloo, a reporting person hereunder, may be deemed to beneficially own the shares of common stock held by Bacterial Robotics.

4. The warrants were issued on January 28, 2014 in connection with an Agreement and Plan of Merger, dated as of November 25, 2013, by and among the Company, Pilus Acquisition, LLC, Bacterial Robotics, Pilus Energy LLC ("Pilus Energy") and certain individuals named therein (the "Merger Agreement"), as consideration for the acquisition of Pilus Energy by the Company.

5. The warrants were issued pursuant to the Merger Agreement and are held by parties to the Voting Agreement, dated January 28, 2014, by and among the Company and members of Pilus Energy (the "Voting Agreement"). Excludes the warrant held by Bacterial Robotics, who is a party to the Voting Agreement, reported separately herein. The reporting persons are members of a Section 13(d) "group" as a result of the Voting Agreement. By virtue of the Voting Agreement and as disclosed in the reporting persons' Schedule 13D filed with the Securities and Exchange Commission on May 2, 2014, Mr. Barkeloo, a reporting person hereunder, may be deemed to beneficially own the shares of common stock of the Company underlying the warrants, which will be subject to the Voting Agreement once issued. Mr. Barkeloo disclaims beneficial ownership of the securities held by the parties to the Voting Agreement.

6. The warrant was issued pursuant to the Merger Agreement and is owned directly by Bacterial Robotics, a reporting person hereunder. As managing member and Chief Executive Officer of Bacterial Robotics and by virtue of the Voting Agreement, Mr. Barkeloo, a reporting person hereunder, may be deemed to beneficially own the securities held by Bacterial Robotics.

Remarks:

EXPLANATORY NOTE: This amended Form 4 is being filed to correct errors in Table II, Box 5 in the previous Form 4 filing of the reporting persons, as the acquisition of warrants was inadvertently reported in the disposition column for both entries. No other changes were made to the previously filed Form 4.

	/s/ Jason E. Barkeloo, Chief Executive Officer of Bacterial Robotics, LLC	05/05/2014
	/s/ Jason E. Barkeloo	05/05/2014
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.